Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 294

1.

Positron emission tomography of herpes simplex virus 1 oncolysis.

Kuruppu D, Brownell AL, Zhu A, Yu M, Wang X, Kulu Y, Fuchs BC, Kawasaki H, Tanabe KK.

Cancer Res. 2007 Apr 1;67(7):3295-300.

2.

Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.

Jacobs A, Tjuvajev JG, Dubrovin M, Akhurst T, Balatoni J, Beattie B, Joshi R, Finn R, Larson SM, Herrlinger U, Pechan PA, Chiocca EA, Breakefield XO, Blasberg RG.

Cancer Res. 2001 Apr 1;61(7):2983-95.

3.

Molecular-genetic PET imaging using an HSV1-tk mutant reporter gene with enhanced specificity to acycloguanosine nucleoside analogs.

Najjar AM, Nishii R, Maxwell DS, Volgin A, Mukhopadhyay U, Bornmann WG, Tong W, Alauddin M, Gelovani JG.

J Nucl Med. 2009 Mar;50(3):409-16. doi: 10.2967/jnumed.108.058735. Epub 2009 Feb 17.

4.
5.

HSV-1 viral oncolysis and molecular imaging with PET.

Kuruppu D, Dorfman JD, Tanabe KK.

Curr Cancer Drug Targets. 2007 Mar;7(2):175-80. Review.

PMID:
17346109
6.

PET of cardiac transgene expression: comparison of 2 approaches based on herpesviral thymidine kinase reporter gene.

Miyagawa M, Anton M, Haubner R, Simoes MV, St├Ądele C, Erhardt W, Reder S, Lehner T, Wagner B, Noll S, Noll B, Grote M, Gambhir SS, Gansbacher B, Schwaiger M, Bengel FM.

J Nucl Med. 2004 Nov;45(11):1917-23.

7.

Imaging progress of herpes simplex virus type 1 thymidine kinase suicide gene therapy in living subjects with positron emission tomography.

Yaghoubi SS, Barrio JR, Namavari M, Satyamurthy N, Phelps ME, Herschman HR, Gambhir SS.

Cancer Gene Ther. 2005 Mar;12(3):329-39.

PMID:
15592447
8.
9.

A tracer kinetic model for 18F-FHBG for quantitating herpes simplex virus type 1 thymidine kinase reporter gene expression in living animals using PET.

Green LA, Nguyen K, Berenji B, Iyer M, Bauer E, Barrio JR, Namavari M, Satyamurthy N, Gambhir SS.

J Nucl Med. 2004 Sep;45(9):1560-70.

10.

Human pharmacokinetic and dosimetry studies of [(18)F]FHBG: a reporter probe for imaging herpes simplex virus type-1 thymidine kinase reporter gene expression.

Yaghoubi S, Barrio JR, Dahlbom M, Iyer M, Namavari M, Satyamurthy N, Goldman R, Herschman HR, Phelps ME, Gambhir SS.

J Nucl Med. 2001 Aug;42(8):1225-34.

11.

Molecular imaging with bioluminescence and PET reveals viral oncolysis kinetics and tumor viability.

Kuruppu D, Brownell AL, Shah K, Mahmood U, Tanabe KK.

Cancer Res. 2014 Aug 1;74(15):4111-21. doi: 10.1158/0008-5472.CAN-13-3472. Epub 2014 May 29.

12.
14.

Prodrug bioactivation and oncolysis of diffuse liver metastases by a herpes simplex virus 1 mutant that expresses the CYP2B1 transgene.

Pawlik TM, Nakamura H, Mullen JT, Kasuya H, Yoon SS, Chandrasekhar S, Chiocca EA, Tanabe KK.

Cancer. 2002 Sep 1;95(5):1171-81.

15.

MicroPET imaging of prostate cancer in LNCAP-SR39TK-GFP mouse xenografts.

Yang H, Berger F, Tran C, Gambhir SS, Sawyers CL.

Prostate. 2003 Apr 1;55(1):39-47.

PMID:
12640659
16.

Oncolysis by viral replication and inhibition of angiogenesis by a replication-conditional herpes simplex virus that expresses mouse endostatin.

Mullen JT, Donahue JM, Chandrasekhar S, Yoon SS, Liu W, Ellis LM, Nakamura H, Kasuya H, Pawlik TM, Tanabe KK.

Cancer. 2004 Aug 15;101(4):869-77.

17.

18F-FEAU as a radiotracer for herpes simplex virus thymidine kinase gene expression: in-vitro comparison with other PET tracers.

Buursma AR, Rutgers V, Hospers GA, Mulder NH, Vaalburg W, de Vries EF.

Nucl Med Commun. 2006 Jan;27(1):25-30.

PMID:
16340720
18.

Imaging immediate-early and strict-late promoter activity during oncolytic herpes simplex virus type 1 infection and replication in tumors.

Yamamoto S, Deckter LA, Kasai K, Chiocca EA, Saeki Y.

Gene Ther. 2006 Dec;13(24):1731-6. Epub 2006 Jul 27.

PMID:
16871231
19.
20.

Quantitation of pulmonary transgene expression with PET imaging.

Richard JC, Zhou Z, Chen DL, Mintun MA, Piwnica-Worms D, Factor P, Ponde DE, Schuster DP.

J Nucl Med. 2004 Apr;45(4):644-54.

Items per page

Supplemental Content

Write to the Help Desk